Automated Antibody Verification for Lead Discovery

In this application note, automated characterization of monoclonal antibodies as therapeutic agents in the pharmaceutical industry is discussed. Several steps within the antibody lead discovery and optimization process require the expression, purification and analytical characterization of the respective antibodies or antibody fragments. Automation of these processes at each stage during the therapeutic pipeline improves high throughput capabilities.